1-8 of 8
William S. Dalton, MD, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Age Is the Strongest Independent Prognostic Factor in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation: Moffitt Cancer Center Experience

Costanza Paoletti, Lodovico Balducci, MD, Ivette Boler, RN, Mihaela Popa-McKiver, MD, PhD, Martine Externann, MD, PhD, Jyotishankar Raychaudury, MD, Claudio Anasetti, MD, Hugo F. Fernandez, MD, Daniel Sullivan, MD, MS, William S. Dalton, MD, PhD, Teresa Field, Ernesto Ayala, MD, Mohamed A Kharfan-Dabaja, MD, Lia Perez, MD, Janelle Perkins, William E. Janssen, PhD, John Harris, Michael Schell, Rachna Kapoor, MD, MPH, Melissa Alsina, J. Leonel Ochoa-Bayona
Journal: Blood
Blood (2008) 112 (11): 4435.
https://doi.org/10.1182/blood.V112.11.4435.4435
Published: 2008
Journal Articles

Influence of Targeted Therapy in Redefining High-Risk Myeloma.

Lori Hazlehurst, PhD, William S. Dalton, MD, PhD, Danielle Yarde, Yulia Nefedova, MD, PhD, Dmitry Gabrilovich
Journal: Blood
Blood (2008) 112 (11): sci-7.
https://doi.org/10.1182/blood.V112.11.sci-7.sci-7
Published: 2008
Journal Articles

Use of MicroRNA Expression Profiling to Identify Prognostic Subclasses in Mantle Cell Lymphoma: Mir-29 Family as New Prognostic Markers

Jianhong Lin, MD, Jianjun Zhao, MD, PhD, Tint Lwin, MD, PhD, Sophie Dessureault, MD, PhD, Lynn C. Moscinski, MD, William S. Dalton, MD, PhD, Eduardo Sotomayor, MD, Jin Cheng, MD, PhD, Jianguo Tao, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 3744.
https://doi.org/10.1182/blood.V112.11.3744.3744
Published: 2008
Journal Articles

A New Target in Multiple Myeloma: Inhibition of Notch Pathway Induces Apoptosis and Enhances Drug Sensitivity of Myeloma Cells In Vitro and In Vivo.

Yulia Nefedova, MD, PhD, Krista Verali, Daniel M. Sullivan, MD, William S. Dalton, MD, PhD, Dmitry I. Gabrilovich, MD, PhD
Journal: Blood
Blood (2006) 108 (11): 841.
https://doi.org/10.1182/blood.V108.11.841.841
Published: 2006
Journal Articles

The Proteasome Inhibitor PR-171 Inhibits Cell Growth, Induces Apoptosis, and Overcomes De Novo and Acquired Drug Resistance in Human Multiple Myeloma Cells.

Douglas Ivancsits, Rama Nimmanapali, PhD, Megan Sun, Kevin Shenk, Susan D. Demo, PhD, Mark K. Bennett, PhD, William S. Dalton, MD, PhD, Melissa Alsina, MD
Journal: Blood
Blood (2005) 106 (11): 1575.
https://doi.org/10.1182/blood.V106.11.1575.1575
Published: 2005
Journal Articles

β1 Integrin Activation Via FN Adhesion Enhances IL-6 Response in Myeloma Cells.

Kenneth H. Shain, PhD, Danielle N. Kelsch, BS, Mei Huang, PhD, Melissa Alsina, MD, Richard Jove, PhD, William S. Dalton, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 2352.
https://doi.org/10.1182/blood.V104.11.2352.2352
Published: 2004
Journal Articles

Influence of Fibronectin,(FN), Adhesion on Gene Expression Profiles, (GEP), of Isolated Patient Myeloma Cells.

Melissa Alsina, MD, Ramadevi Nimmanapalli, PhD, Mackley A. Paul, Gerbino Elvira, Lori Hazlehurst, Ph.D, Steven Enkemann, PhD, Beam Craig, PhD, William S. Dalton, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 2345.
https://doi.org/10.1182/blood.V104.11.2345.2345
Published: 2004
Journal Articles

Characterization of a R115777 Resistant Human Multiple Myeloma Cell Line with Cross-Resistance to PS-341.

Robert W. Buzzeo, BS, Steven A. Enkemann, PhD, Ramadevi Nimmanapalli, PhD, Melissa Alsina, MD, Mathias G. Lichtenheld, MD, William S. Dalton, MD, PhD, Darrin M. Beaupre, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 3363.
https://doi.org/10.1182/blood.V104.11.3363.3363
Published: 2004